59 filings
8-K
PASG
Passage Bio Inc
22 May 24
Submission of Matters to a Vote of Security Holders
4:03pm
8-K
PASG
Passage Bio Inc
14 May 24
Passage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
7:01am
8-K
PASG
Passage Bio Inc
4 Mar 24
Passage Bio Reports Fourth Quarter and Full-year 2023 Financial Results and Provides Recent Business Highlights
7:02am
8-K
PASG
Passage Bio Inc
29 Feb 24
Other Events
4:06pm
8-K
PASG
Passage Bio Inc
5 Jan 24
Regulation FD Disclosure
4:05pm
8-K
34uqbdaulfy8n0g0
29 Dec 23
In the Court of Chancery of the State of Delaware
4:15pm
8-K
3729cnd65
20 Dec 23
Passage Bio Announces Promising Initial Data from Phase 1/2 Clinical Trial of PBFT02 In FTD-GRN and Updated Strategic Priorities
7:05am
8-K
jp5sib323
13 Nov 23
Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
7:00am
8-K
oip4ji1a32n9 s3
1 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:10pm
8-K
o2blg9ysxb5jp91 lst
7 Aug 23
Passage Bio Reports Second Quarter 2023 Financial Results and Provides Recent Business Highlights
7:15am
8-K
50mqei6vt 5fgzby
31 Jul 23
Departure of Directors or Certain Officers
7:00am
8-K
gwjxcwds 936s
20 Jul 23
Departure of Directors or Certain Officers
7:00am
8-K
sxrao17zlecz7h00
26 May 23
Submission of Matters to a Vote of Security Holders
12:00am
8-K
utz9j
11 May 23
Passage Bio Reports First Quarter 2023 Financial Results and Provides Recent Business Highlights
7:09am
8-K
mtzc2m
6 Apr 23
Entry into a Material Definitive Agreement
4:30pm
8-K
1dmefthaxs 9fx716
10 Mar 23
Regulation FD Disclosure
4:41pm
8-K
fhele m0z4jv2m
6 Mar 23
Passage Bio Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Recent Business Highlights
7:01am
8-K
ztslt wlfu7
24 Feb 23
Passage Bio Presents Additional Interim Data from Imagine-1 Study for GM1 Gangliosidosis at 19th Annual WORLDSymposiumâ„¢ 2023
7:00am
8-K
vurs7jm1kpgpoy4tfk8
9 Jan 23
Results of Operations and Financial Condition
7:02am
8-K
ch3tv5imxza
14 Dec 22
Passage Bio Announces Positive Interim Clinical Data from First Six Patients with GM1 Gangliosidosis in Imagine-1 Study
7:00am